Andrea Giacomelli

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 251 publications

High Baseline Prevalence and Stable Incidence of Chlamydia and Gonorrhea During the First Year of HIV Pre-Exposure Prophylaxis: A Multicenter Italian Cohort Study.

High Baseline Prevalence and Stable Incidence of Chlamydia and Gonorrhea During the First Year of HIV Pre-Exposure Prophylaxis: A Multicenter Italian Cohort Study.

Journal: Sexually transmitted diseases

Published: August 14, 2026

Management of ritonavir shortage in people with long-standing HIV infection: A single-centre experience.

Management of ritonavir shortage in people with long-standing HIV infection: A single-centre experience.

Journal: HIV medicine

Published: June 17, 2026

Repeated Detection of Vaccine-Preventable Anal HPV Genotypes in a Screened Cohort: A Retrospective Observational Study.

Repeated Detection of Vaccine-Preventable Anal HPV Genotypes in a Screened Cohort: A Retrospective Observational Study.

Journal: Pathogens (Basel, Switzerland)

Published: June 08, 2026

Impact of Sex Assigned At Birth and HIV Acquisition Route on Long-Acting Cabotegravir plus Rilpivirine Persistence: A Real-World Cohort Study.

Impact of Sex Assigned At Birth and HIV Acquisition Route on Long-Acting Cabotegravir plus Rilpivirine Persistence: A Real-World Cohort Study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: May 14, 2026

Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV on Any Antiretroviral Therapy Regimen: The Retrospective ESSENTIAL Study.

Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV on Any Antiretroviral Therapy Regimen: The Retrospective ESSENTIAL Study.

Journal: Infectious diseases and therapy

Published: April 25, 2026

Statin use and LDL cholesterol target attainment in people with HIV after European AIDS Clinical Society 2024 guideline updates.

Statin use and LDL cholesterol target attainment in people with HIV after European AIDS Clinical Society 2024 guideline updates.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: April 21, 2026

Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis.

Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis.

Journal: Antimicrobial agents and chemotherapy

Published: April 15, 2026

How do I screen for tuberculosis and provide tuberculosis preventive treatment in people with HIV?

How do I screen for tuberculosis and provide tuberculosis preventive treatment in people with HIV?

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: April 14, 2026

Non-AIDS-Defining Cancer Incidence in People With HIV in Milan, Italy, 2000-2023: Temporal Trends and Comparison With the General Population.

Non-AIDS-Defining Cancer Incidence in People With HIV in Milan, Italy, 2000-2023: Temporal Trends and Comparison With the General Population.

Journal: International journal of cancer

Published: April 12, 2026

Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study.

Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study.

Journal: EClinicalMedicine

Published: March 10, 2026

Virological outcomes of PWH who discontinued cabotegravir/rilpivirine long-acting therapy in a real-world context.

Virological outcomes of PWH who discontinued cabotegravir/rilpivirine long-acting therapy in a real-world context.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 04, 2026

Extreme Cardiovascular Risk and LDL-C Target Achievement in People With HIV.

Extreme Cardiovascular Risk and LDL-C Target Achievement in People With HIV.

Journal: Open forum infectious diseases

Published: February 27, 2026

Showing 1-12 of 251

Last Updated: 09/26/2026